News
MDimune and Evercyte form partnership for developing tumor-targeting EVs
MDimune and Evercyte form partnership for developing tumor-targeting EVs April 1, 2021,
Mass production of spheroids from ASC/TERT1
Mass production of spheroids from ASC/TERT1 standardized
Lecture on 3Rs
Lecture on 3Rs (replacement-reduction-refinement) of animal experiments New lecture on